Amr Soliman to Cost-Benefit Analysis
This is a "connection" page, showing publications Amr Soliman has written about Cost-Benefit Analysis.
Connection Strength
0.265
-
Skrundevskiy AN, Omar OS, Kim J, Soliman AS, Korolchuk TA, Wilson FA. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries. Value Health Reg Issues. 2018 Sep; 16:22-27.
Score: 0.132
-
Kim DD, Hutton DW, Raouf AA, Salama M, Hablas A, Seifeldin IA, Soliman AS. Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence. Glob Public Health. 2015; 10(3):296-317.
Score: 0.104
-
Nelson S, Kim J, Wilson FA, Soliman AS, Ngoma T, Kahesa C, Mwaiselage J. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries. Value Health Reg Issues. 2016 09; 10:1-6.
Score: 0.029